Advertisement

Picture Campus Berlin-Buch GmbH CBB Location of Future Innovation 650x100px
Person › Details

Stéphane Boissel (SparingVision S.A.S.)

Boissel, Stéphane (SparingVision 202010– CEO before Sangamo + TxCell + Genclis + Transgene + Innate Pharma + Lazard)

 

Organisations Organisation SparingVision S.A.S.
  Former/major organisation TxCell S.A. (Euronext Paris: TXCL)
Products Product SPVN06 mutation-agnostic AAV gene therapy for ofretinitis pigmentosa (SparingVision)
  Product 2 gene therapy
     


Advertisement

Picture Wirtschaftsförderung Sachsen Life Sciences in Saxony 650x200px


More documents for Stéphane Boissel


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Campus Berlin-Buch GmbH BBC BerlinBioCube Start-up Center 650x300px




» top